Presentation is loading. Please wait.

Presentation is loading. Please wait.

Continuing versus discontinuing antiplatelet drugs, vasodilators, and/or cerebral ameliorators on perioperative total blood loss in total knee arthroplasty.

Similar presentations


Presentation on theme: "Continuing versus discontinuing antiplatelet drugs, vasodilators, and/or cerebral ameliorators on perioperative total blood loss in total knee arthroplasty."— Presentation transcript:

1 Continuing versus discontinuing antiplatelet drugs, vasodilators, and/or cerebral ameliorators on perioperative total blood loss in total knee arthroplasty without pneumatic tourniquet  Sachiyuki Tsukada, MD, Motohiro Wakui, MD  Arthroplasty Today  Volume 4, Issue 1, Pages (March 2018) DOI: /j.artd Copyright © 2017 The Authors Terms and Conditions

2 Figure 1 Participant flow chart.
Arthroplasty Today 2018 4, 89-93DOI: ( /j.artd ) Copyright © 2017 The Authors Terms and Conditions


Download ppt "Continuing versus discontinuing antiplatelet drugs, vasodilators, and/or cerebral ameliorators on perioperative total blood loss in total knee arthroplasty."

Similar presentations


Ads by Google